Sample results
Increased cancer risk refers to elevated likelihood of developing cancer due to genetic, environmental, or lifestyle factors. It is caused by chronic inflammation, cellular damage, and abnormal cell proliferation processes that create conditions favorable for cancer development. The AspirinWorks 11-Dehydrothromboxane B2 (11-dhTXB2) with Creatinine test is the most important test for assessing inflammation-related cancer risk factors.
Increased cancer risk is caused by a combination of chronic inflammation, genetic mutations, environmental toxins, and lifestyle factors that damage cellular DNA. Chronic inflammation produces inflammatory molecules like 11-dhTXB2 that promote cell proliferation and create an environment where abnormal cells can grow. Other contributing factors include tobacco use, excessive alcohol consumption, obesity, UV radiation exposure, certain viral infections like HPV and hepatitis, family history of cancer, and exposure to carcinogens like asbestos or radon.
The AspirinWorks 11-Dehydrothromboxane B2 (11-dhTXB2) with Creatinine test is the most important test for assessing inflammation-related cancer risk because it detects levels of 11-dhTXB2, a biomarker directly involved in inflammation and cell proliferation pathways that research has linked to cancer development. Elevated 11-dhTXB2 levels indicate increased inflammatory activity that could create conditions favorable for certain types of cancer. While no single blood test can predict cancer definitively, this biomarker provides valuable insights into inflammatory processes that may influence cancer risk and can help healthcare providers identify individuals who may benefit from preventive interventions or closer monitoring.
You should get tested if you have a strong family history of cancer, have been exposed to known carcinogens, have chronic inflammatory conditions, are a current or former smoker, or have lifestyle factors like obesity or excessive alcohol use that increase cancer risk. Testing is also recommended if you have unexplained persistent symptoms like fatigue, unexplained weight loss, or chronic pain. Early assessment of inflammation markers can help you and your healthcare provider develop a personalized prevention strategy and monitoring plan to reduce your cancer risk through lifestyle modifications and targeted interventions.
What this means
Your 11-dhTXB2 level is elevated, suggesting that aspirin may not be fully blocking platelet activity in your body. This indicates possible aspirin resistance, meaning you might not be getting the full cardiovascular protection expected from your aspirin therapy. This finding is important to discuss with your doctor to optimize your treatment plan.
Recommended actions
Discuss your results with your doctor to consider adjusting aspirin dose or adding alternative antiplatelet therapy
Ensure you're taking aspirin consistently at the same time each day as prescribed
Avoid NSAIDs like ibuprofen which can interfere with aspirin's effectiveness
Retest in 4-8 weeks after any treatment adjustments to confirm improved response
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: